These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2068179)

  • 1. Biological analysis of neuroblastoma in mass screened negative cases.
    Ishimoto K; Kiyokawa N; Fujita H; Yabuta K; Ohya T; Miyano T; Shinohara T; Sera Y
    Prog Clin Biol Res; 1991; 366():603-8. PubMed ID: 2068179
    [No Abstract]   [Full Text] [Related]  

  • 2. Results of mass screening for neuroblastoma in Sapporo, Japan.
    Takeda T; Nishi M; Shimada M; Nakadate H; Hatae Y; Naito H; Hanai J; Kawai T; Takasugi N
    Prog Clin Biol Res; 1991; 366():595-601. PubMed ID: 2068178
    [No Abstract]   [Full Text] [Related]  

  • 3. Screening for neuroblastoma (NB) in North America: the Quebec Project.
    Woods WG; Lemieux B; Leclerc JM; Bernstein ML; Brisson L; Brossard J; Brodeur GM; Look AT; Robison LL; Shuster JJ
    Prog Clin Biol Res; 1994; 385():377-82. PubMed ID: 7972234
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of a rapid and reliable method for mass screening for neuroblastoma in infants.
    Schilling FH; Oberrauch W; Schanz F; Treuner J
    Prog Clin Biol Res; 1991; 366():579-83. PubMed ID: 2068176
    [No Abstract]   [Full Text] [Related]  

  • 5. History and current status of neuroblastoma screening in Japan.
    Takeda T
    Med Pediatr Oncol; 1989; 17(5):361-3. PubMed ID: 2796850
    [No Abstract]   [Full Text] [Related]  

  • 6. [Diagnosis of neuroblastoma using high pressure liquid chromatography (HPLC)].
    Lato M; Rufini S; Ghebregzabher M
    Minerva Pediatr; 1979 Jul; 31(13):1005-8. PubMed ID: 481367
    [No Abstract]   [Full Text] [Related]  

  • 7. [Paracetamol interference with vanilmandelic and homovanillic acid quantification by the Bio-Rad HPLC kit].
    Drouard-Troalen L; Assicott MJ; Bonnay MM
    Ann Biol Clin (Paris); 2002; 60(5):626-7. PubMed ID: 12405118
    [No Abstract]   [Full Text] [Related]  

  • 8. Screening for neuroblastoma in North America--preliminary results from the Quebec project.
    Woods WG; Tuchman M; Lemieux B
    Prog Clin Biol Res; 1991; 366():585-94. PubMed ID: 2068177
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of mass screening for neuroblastoma and the presumptive natural history of this tumor.
    Takeda T; Shimada M; Iizuka S; Takasugi N
    Prog Clin Biol Res; 1994; 385():383-8. PubMed ID: 7972235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass screening for neuroblastoma in Japan.
    Sawada T; Sugimoto T; Kawakatsu H; Matsumura T; Matsuda Y
    Pediatr Hematol Oncol; 1991; 8(2):93-109. PubMed ID: 1863547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Problems of neuroblastoma screening for 6 month olds and results of second screening for 18 month olds.
    Hayashi Y; Ohi R; Yaoita S; Nakamura M; Kikuchi Y; Konno T; Tsuchiya S; Shiraishi H
    J Pediatr Surg; 1995 Mar; 30(3):467-70. PubMed ID: 7760244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of the VMA test strip.
    Helson L; Bethune V; Schwartz MK
    Pediatrics; 1973 Jan; 51(1):153. PubMed ID: 4684442
    [No Abstract]   [Full Text] [Related]  

  • 13. Screening for neuroblastoma in France: methodological aspects and preliminary observations.
    Chauvin F; Mathieu P; Frappaz D; Lasset C; Favrot MC; Greffe J; Esteve J; Thiesse P; Combaret V; Chauvot P; Boschetti R; David L; Brunat-Mentigny M; Philip T
    Med Pediatr Oncol; 1997 Feb; 28(2):81-91. PubMed ID: 8986143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of infants with neuroblastoma detected by mass screening and surgically treated in Shiga Prefecture, Japan: what is the role of surgery?
    Hase T; Ohta S; Tani T; Mizukuro T; Mekata E; Naitoh H; Shimadera S; Fujino S; Taga T
    Pediatr Surg Int; 2002 Sep; 18(5-6):289-94. PubMed ID: 12415341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rapid determination of 4-hydroxy-3-methoxymandelic (vanilmandelic) acid and 4-hydroxy-3-methoxyphenylacetic (homovanillic) acid in urine by liquid chromatography with electrochemical detection].
    Satokata I; Asami T; Otsuka T; Sakai K
    Rinsho Byori; 1986 Jul; 34(7):817-22. PubMed ID: 3761638
    [No Abstract]   [Full Text] [Related]  

  • 16. [Present status of neuroblastoma mass screening in Japan. Neuroblastoma-Committee of the Japanese Childhood Cancer Society].
    Sawada T; Nagahara N; Ohi R; Yamamoto K; Okabe I; Hanawa Y; Hashizume K; Matsui I; Ohkawa H; Tunoda A
    Gan To Kagaku Ryoho; 1990 Dec; 17(12):2319-26. PubMed ID: 2260868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three years of experience with random urinary homovanillic and vanillylmandelic acid levels in the diagnosis of neuroblastoma.
    Tuchman M; Ramnaraine ML; Woods WG; Krivit W
    Pediatrics; 1987 Feb; 79(2):203-5. PubMed ID: 3808793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening procedures for neuroblastoma: false-negative results.
    Johnsonbaugh RE; Cahill R
    Pediatrics; 1975 Aug; 56(2):267-70. PubMed ID: 1161374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of cut off values for vanillylmandelic acid and homovanillic acid in 24-hr urine accumulation during mass screening for neuroblastoma.
    Nishi M; Miyake H; Takeda T; Takasugi N; Sato Y; Hanai J
    Jpn J Clin Oncol; 1987 Sep; 17(3):221-8. PubMed ID: 3669365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of screening for neuroblastoma at 6 months of age: a retrospective population-based cohort study.
    Hiyama E; Iehara T; Sugimoto T; Fukuzawa M; Hayashi Y; Sasaki F; Sugiyama M; Kondo S; Yoneda A; Yamaoka H; Tajiri T; Akazawa K; Ohtaki M
    Lancet; 2008 Apr; 371(9619):1173-80. PubMed ID: 18395578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.